Mood disturbances in motor neurone disease

Journal of the Neurological Sciences

Volumn 160, Issue SUPPL. 1, 1998, Pages

  Moore, Marian Janet ^a   Moore, Peter Brian ^b   Shaw, Pamela J ^c  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b SOUTH TYNESIDE DISTRICT HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

ALS (amyotrophic lateral sclerosis); Anxiety; Depression; Life events; MND (motor neurone disease); Personality

Indexed keywords

ANXIETY NEUROSIS; CONFERENCE PAPER; DEPRESSION; DISEASE SEVERITY; HUMAN; LIFE EVENT; MOTOR NEURON DISEASE; PERSONALITY; PRIORITY JOURNAL; RATING SCALE;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSION; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; MOTOR NEURON DISEASE; OUTPATIENTS; PERSONALITY TESTS;

EID: 0031724587     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00203-2     Document Type: Conference Paper

References (19)

1. D'Augustino RB, Stevens MA, editors. Goodness of Fit Techniques. New York: Marcel Dekker, 1986:97-106.
2. Beck A, et al. An instrument for measuring depression. Arch Gen Psychiatry 1961;4:561-85.
3. Bocker FM, et al. Disability in everyday tasks and subjective status of patients with advanced amyotrophic lateral sclerosis. Fortschr Neurol Psychiatr 1990;58(4):224-36.
4. Brown GN, Harris T. Social Origins of Depression. A Study of Psychiatric Disorder in Women. London: Routledge, 1978.
5. Brown WA, Meuller PS. Psychological functions in individuals with amyotrophic lateral sclerosis. Psychiatr Med 1970;32:141-52.
6. Eysenck HJ. The Biological Basis of Personality. Thomas, Springfield, IL, 1967.
7. Ferro FM, et al. Psychodynamic aspects in patients with amyotrophic lateral sclerosis. Adv Med Biol 1987;209:313-6.
8. Forrest V, Ince PG, Leitch M, Marshall EF, Shaw PJ. Serotonergic neuro-transmission in the spinal cord and motor cortex of patients with motor neurone disease and controls: qualitative autoradiography for 5-HT1a and 5-HT2 receptors. J Neurol Sci 1996;139(Suppl):83-90.
9. RR Grinker, AL Sahs. Neurology, 6th ed. Thomas, Springfield, IL, 1966.
10. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
11. Holmes TH, Rahe RH. The Social Readjustment Rating Scale. J Psychosom Res 1967;11:213-8.
12. Jenkins R, et al. The prevention of depression and anxiety. The role of the primary care team. London: HMSO, 1992.
13. Lishman WA. Organic Psychiatry. Oxford: Blackwell, 1987.
14. Minitab 10.1, Minitab Inc., 3081 Enterprise Drive, State College PA 16801-3008, 1994.
15. Norris FH, Calanchini PR, Fallat RJ, Psntry S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;34:721-8.
16. Tasker N. The Nature of Cognitive Deficit in MND. BA Thesis, University of Newcastle upon Tyne, 1992.
17. Weissman MM, Mgers JK, Harding PS. Psychiatric disorders in a US urban community. Am J Psychiatry 1978;135:459.
18. Ziegler LH. Psychotic and emotional phenomena associated with amyotrophic lateral sclerosis. Arch Neurol Psychiatry 1930;24:930-6.
19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.